The Institute for the Biotechnology of Infectious Diseases (IBID), at the University of Technology, Sydney (UTS), was established in 2002 to develop a core activity in infectious disease research

IBID has mature research programs in the areas of protozoology, helminthology, and vector biology, and aims to expand into the areas of bacteriology and virology.

RESEARCH FOCUS

IBID's central strategic goal is to develop new means of controlling infectious diseases.

Our overarching vision is to create an infectious disease research environment that is limited only by the imagination of its members. However, going forward, IBID will become -

• A UTS flagship research centre focused on infectious diseases that affect the health and well-being of humans and animals.

• An Institute that will compete, and work with the finest research Institutes in Australia and abroad.

• A collegial, supportive environment that will develop its staff and students so that they are sought after by other Institutions.

• An Institute that will attract the best researchers in UTS, Australia and abroad.

So why study infectious diseases?

Infectious diseases are an important global animal and human health problem. Research on infectious agents are a priority for all first world countries, including Australia, due to the -

• emergence of new pathogens

• increasing number of antibiotic and drug resistant pathogens

• increasing number of emerging and re-emerging zoonotic diseases.

• geographical widening of existing diseases

• imminent threat to biosecurity

Consequently , IBID's research perspective is that by understanding the lifecycle and biology of these pathogens we can respond to the urgent need for -

• diagnostics for the early detection of pathogens

• methods for identifying and monitoring vectors of diseases

• effective treatments or therapies with new mechanisms of actions

• vaccines that can prevent infection and disease